Seminars in Oncology Nursing
Volume 25, Issue 2 , Pages 151-158 , May 2009

Management Issues In Hematopoietic Stem Cell Transplantation

  • Robert David Rice

      Affiliations

    • Corresponding Author InformationAddress correspondence to Robert David Rice, RN, PhD, AOCNP®, 1275 York Ave, Box 334, New York, NY 10065
    • ,
  • Gay Bailey

References 

  1. Pasquini M, Wang Z, Schneider L. Report on state of the art in blood and marrow transplantation. IBMTR/ABMTR Newsletter. 2007;13:5–9
  2. Campbell LR, Foody MC. Administrative issues of an inpatient BMT unit. In:  Buchsel PC,  Whedon MB editor. Bone marrow transplantation: administrative and clinical strategies. Boston, MA: Jones and Bartlett; 1995;p. 39–68
  3. Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328–340
  4. Sheretz RJ, Belani A, Kramer BS, et al. Impact of air filtration on nosocomial aspergillus infections: unique risk of bone marrow transplant patients. Am J Med. 1987;83:709–718
  5. Siegel JD, Rhinehart E, Jackson M, et al, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. June 2007. Available at: http://www.cdc.gov/ncidod/dhqp/index.html# (accessed Oct 5, 2008).
  6. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendation of the Centers for Disease Control, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2000;6(suppl):7–83
  7. Welte K, Gabrilove J, Bronchud MH, et al. Filgrastim (r-metHuG-CSF): the first 10 years. Blood. 1996;88:1907–1929
  8. Schmitz N, Linch DC, Dreger P, et al. Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet. 1996;347:353–357
  9. Svahn BM, Bjurman B, Myrback KE, et al. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant. 2000;26:1057–1060
  10. Gluck S, des Rochers C, Cano C, et al. High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplant. 1997;20:431–434
  11. Herrmann RP, Trent M, Cooney J, et al. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 1999;24:1213–1217
  12. Meisenberg BR, Ferran K, Hollenbach K, et al. Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant. 1998;21:927–932
  13. Bredeson C, Perry G, Martens C, et al. Outpatient total body irradiation as a component of a comprehensive outpatient transplant program. Bone Marrow Transplant. 2002;29:667–671
  14. Frey P, Stinson T, Siston A, et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant. 2002;30:741–748
  15. Clifford KN. peripheral stem cell transplantation in the community setting. In:  Buchsel PC,  Kapustay PM editor. Stem cell transplantation: a clinical textbook. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 12.3–12.13
  16. Kelley CH, Rudder Randolph S, Leum E. Home care of peripheral stem cell transplantation recipients. In:  Buchsel PC,  Kapustay PM editor. Stem cell transplantation: a clinical textbook. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 13.3–13.16
  17. Buchsel PC, Kapustay PM. Models of ambulatory care for blood cell and bone marrow transplantation. Ed 2. In:  Whedon MB,  Wujcik D editor. Blood and marrow stem cell transplantation. Boston, MA: Jones and Bartlett; 1997;p. 525–561
  18. Buchsel PC. Administrative issues of an ambulatory care setting. In:  Buchsel PC,  Whedon MB editor. Bone marrow transplantation: administrative and clinical strategies. Boston, MA: Jones and Bartlett; 1995;p. 19–38
  19. Adams LL, Johns AA. Clinical and administrative support for hematopoietic cell transplant programs. In:  Blume KG,  Forman SJ,  Appelbaum FR editor. Thomas' hematopoietic cell transplantation. Ed 3. Malden, MA: Blackwell Publishing; 2004;p. 463–468
  20. Lanier WL, Rose SH. The contemporary medical community: leadership, mentorship, and career choices. Mayo Clin Proc. 2008;83:974–977
  21. Aiken LH, Clarke SP, Sloane DM, et al. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA. 2002;288:1987–1993
  22. Cho SH, Hwang JH, Kim J. Nurse staffing and patient mortality in intensive care units. Nurs Res. 2008;57:322–330
  23. Article 139, New York State Nurse Practice Act. Available at: http://www.op.nysed.gov/article139.htm (accessed Oct 5, 2008).
  24. Guidelines regarding utilization of licensed nurses (RNs and LPNs) and unlicensed assistive personnel (UAP) in the delivery of nursing care. Available at: http://www.nysna.org/images/pdfs/practice/scope/rn_uap_guidelines04.pdf. (accessed Oct 5, 2008).
  25. Cooke L, Gemmill R, Grant M. Advanced practice nurses core competencies: a framework for developing and testing an advanced practice nurse discharge intervention. Clin Nurs Spec. 2008;22:218–224
  26. American Federation of Clinical Oncologic Societies. Access to quality cancer care: consensus statement. J Clin Oncol. 1998;16:1628–1630
  27. US Food and Drug Administration . Current good tissue practice for human cells, tissues, and cellular and tissue-based product establishments; inspection and enforcement. Food and Drug Administration 21 CFR Parts 16, 1270 and 1271. Federal Register. 2004;69(226):68612–68688
  28. Adams JJ, Brodie C, Wilkins LA. Managed care and peripheral stem cell transplantation. In:  Buchsel PC,  Kapustay PM editor. Stem cell transplantation: a clinical textbook. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 18.3–18.14
  29. LeMaistre CF, Loberiza FR. What is quality in a transplant program?. Biol Blood Marrow Transplant. 2005;11:241–246
  30. FACT-JACIE (Foundation for the Accreditation of Cellular Therapy and Joint Accreditation Committee of the International Society of Cellular Therapy and the European Group for Blood and Marrow Transplantation) International Standards for Cellular Therapy Product Collection, Processing and Administration. Ed 4. 2008. Available at: http://www.factwebsite.org/uploadedFiles/News/4th%20Ed.%20Standards%20for%20Web.pdf (accessed Oct 5, 2008).

PII: S0749-2081(09)00028-X

doi: 10.1016/j.soncn.2009.03.009

Seminars in Oncology Nursing
Volume 25, Issue 2 , Pages 151-158 , May 2009

Article Tools